• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对美国东南部高血压、血脂异常和胰岛素抵抗的全球心血管风险。

Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.

作者信息

Houston Mark C, Basile Jan, Bestermann William H, Egan Brent, Lackland Daniel, Hawkins Ralph G, Moore Michael A, Reed James, Rogers Philip, Wise Daniel, Ferrario Carlos M

机构信息

Consortium for Southeastern Hypertension Control (COSEHC) and Vanderbilt University School of Medicine and St. Thomas Hospital, Nashville, Tennessee, USA.

出版信息

Am J Med Sci. 2005 Jun;329(6):276-91. doi: 10.1097/00000441-200506000-00008.

DOI:10.1097/00000441-200506000-00008
PMID:15958870
Abstract

An expanded occurrence of the metabolic syndrome in the U.S. population, especially in the Southeastern United States, has raised awareness of a need to revise our approach to the management of global cardiovascular risk factors while underscoring a need for more aggressive interventions and prevention measures. In defining the components of the metabolic syndrome and the interrelationship among obesity, hypertension, dyslipidemia, and insulin resistance, a basic framework for the medical management of this syndrome has been defined. In Part I of the consensus report prepared by the Workgroup on Medical Guidelines of the Consortium for Southeastern Hypertension Control (COSEHC), we analyze the components of the metabolic syndrome, discuss its pathophysiology, and recommend an approach to the quantitative analysis of the risk factors contributing to excess cardiovascular death in the region.

摘要

代谢综合征在美国人群中,尤其是美国东南部地区,呈现出扩大化的态势,这提高了人们对于修订全球心血管危险因素管理方法的认识,同时也凸显了采取更积极干预措施和预防措施的必要性。在界定代谢综合征的组成部分以及肥胖、高血压、血脂异常和胰岛素抵抗之间的相互关系时,已经确定了该综合征医学管理的基本框架。在东南高血压控制联盟(COSEHC)医学指南工作组编写的共识报告第一部分中,我们分析了代谢综合征的组成部分,讨论了其病理生理学,并推荐了一种对该地区导致心血管死亡过多的危险因素进行定量分析的方法。

相似文献

1
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.应对美国东南部高血压、血脂异常和胰岛素抵抗的全球心血管风险。
Am J Med Sci. 2005 Jun;329(6):276-91. doi: 10.1097/00000441-200506000-00008.
2
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.应对美国东南部高血压、血脂异常、糖尿病和代谢综合征的全球心血管风险,第二部分:高血压、血脂异常、糖尿病和代谢综合征全球心血管风险管理的治疗建议
Am J Med Sci. 2005 Jun;329(6):292-305. doi: 10.1097/00000441-200506000-00009.
3
Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.合并高血压和血脂异常的患病率及相关心血管疾病
Am J Manag Care. 2004 Dec;10(12):926-32.
4
The individual components of the metabolic syndrome: is there a raison d'etre?代谢综合征的各个组成部分:是否有存在的理由?
J Am Coll Nutr. 2007 Jun;26(3):191-5. doi: 10.1080/07315724.2007.10719601.
5
COSEHC global vascular risk management quality improvement program: rationale and design.COSEHC全球血管风险管理质量改进项目:基本原理与设计
Vasc Health Risk Manag. 2010;6:1135-45. doi: 10.2147/VHRM.S13746. Epub 2010 Dec 13.
6
Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis.通过人体测量学方法检测德黑兰成年人的心血管危险因素:受试者工作特征(ROC)曲线分析。
Eur J Clin Nutr. 2004 Aug;58(8):1110-8. doi: 10.1038/sj.ejcn.1601936.
7
A major health hazard: the metabolic syndrome.一种主要的健康危害:代谢综合征。
Life Sci. 2003 Sep 26;73(19):2395-411. doi: 10.1016/s0024-3205(03)00646-5.
8
Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science.冠心病中代谢综合征的危险因素簇:科学现状
Dimens Crit Care Nurs. 2005 Mar-Apr;24(2):64-9. doi: 10.1097/00003465-200503000-00005.
9
Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension.
J Fam Pract. 1994 Jan;38(1):17-23.
10
Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.年轻成年人的中心性肥胖、代谢综合征与纤溶酶原激活物抑制剂-1
J Am Acad Nurse Pract. 2005 Dec;17(12):535-41. doi: 10.1111/j.1745-7599.2005.00083.x.

引用本文的文献

1
Body weight variability is not associated with changes in risk factors for cardiometabolic disease.体重变异性与心血管代谢疾病风险因素的变化无关。
Int J Cardiol Hypertens. 2020 Aug 2;6:100045. doi: 10.1016/j.ijchy.2020.100045. eCollection 2020 Sep.
2
Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia.沙特阿拉伯2型糖尿病成年患者血脂异常的患病率及相关因素
Diabetes Metab Syndr Obes. 2020 Oct 28;13:4033-4040. doi: 10.2147/DMSO.S246068. eCollection 2020.
3
The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.
无创心血管检测、应用临床营养及营养补充剂在冠心病防治中的作用。
Ther Adv Cardiovasc Dis. 2018 Mar;12(3):85-108. doi: 10.1177/1753944717743920. Epub 2018 Jan 10.
4
Prevalence of dyslipidaemia and risk factors in Chinese coal miners: a cross-sectional survey study.中国煤矿工人血脂异常患病率及相关危险因素的横断面调查研究。
Lipids Health Dis. 2017 Aug 23;16(1):161. doi: 10.1186/s12944-017-0548-9.
5
Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen.深圳成年人群血脂异常的血清脂质及相关因素
Lipids Health Dis. 2015 Jul 14;14:71. doi: 10.1186/s12944-015-0073-7.
6
High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.中国农村成年人血脂异常及相关危险因素的高患病率。
Lipids Health Dis. 2014 Dec 12;13:189. doi: 10.1186/1476-511X-13-189.
7
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.COSEHC™全球血管风险管理质量改进项目:首次随访报告。
Vasc Health Risk Manag. 2013;9:391-400. doi: 10.2147/VHRM.S44950. Epub 2013 Jul 22.
8
Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.几种遗传多态性与超重/肥胖相互作用,影响血清脂质水平。
Cardiovasc Diabetol. 2012 Oct 8;11:123. doi: 10.1186/1475-2840-11-123.
9
COSEHC global vascular risk management quality improvement program: rationale and design.COSEHC全球血管风险管理质量改进项目:基本原理与设计
Vasc Health Risk Manag. 2010;6:1135-45. doi: 10.2147/VHRM.S13746. Epub 2010 Dec 13.
10
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).用行为和人体测量因素提高全球血管风险预测。多民族 NOMAS(北方曼哈顿队列研究)。
J Am Coll Cardiol. 2009 Dec 8;54(24):2303-11. doi: 10.1016/j.jacc.2009.07.047.